tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CLNN Stock Latest News

Clene Secures $10M Debt Facility to Enhance Position
Company AnnouncementsClene Secures $10M Debt Facility to Enhance Position
29d ago
8K
CLNN
Clene secures debt facility to pay off existing senior loan
PremiumThe Fly
Clene secures debt facility to pay off existing senior loan
1M ago
CLNN
Clene Gains FDA Support for ALS Treatment Approval
PremiumCompany Announcements
Clene Gains FDA Support for ALS Treatment Approval
1M ago
8K
CLNN
Clene receives written guidance from DN1 of U.S. FDA on pathway for CNM-Au8
PremiumThe Fly
Clene receives written guidance from DN1 of U.S. FDA on pathway for CNM-Au8
1M ago
CLNN
Clene price target lowered to $84 from $90 at Benchmark
PremiumThe Fly
Clene price target lowered to $84 from $90 at Benchmark
2M ago
CLNN
Clene price target lowered to $83 from $86 at Canaccord
PremiumThe FlyClene price target lowered to $83 from $86 at Canaccord
2M ago
CLNN
Clene Announces Q3 2024 Results and ALS Drug Progress
Premium
Company Announcements
Clene Announces Q3 2024 Results and ALS Drug Progress
2M ago
8K
CLNN
Clene reports Q3 EPS ($1.22), consensus ($1.32)
Premium
The Fly
Clene reports Q3 EPS ($1.22), consensus ($1.32)
2M ago
CLNN
CLNN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CLNN Upcoming Earnings Report: What to Expect?
3M ago
CLNN
Clene Unveils Phase 3 Trial Design at NEALS
PremiumCompany Announcements
Clene Unveils Phase 3 Trial Design at NEALS
3M ago
8K
CLNN
Clene price target lowered to $86 from $94 at Canaccord
PremiumThe Fly
Clene price target lowered to $86 from $94 at Canaccord
4M ago
CLNN
Clene announces $7.3M registered direct offering, private placements
PremiumThe Fly
Clene announces $7.3M registered direct offering, private placements
4M ago
CLNN
Clene announces it will meet in-person with FDA to discuss CNM-Au8
PremiumThe FlyClene announces it will meet in-person with FDA to discuss CNM-Au8
4M ago
CLNN
Clene initiated with a Buy at EF Hutton
Premium
The Fly
Clene initiated with a Buy at EF Hutton
4M ago
CLNN
Clene sees cash runway into 4Q24
Premium
The Fly
Clene sees cash runway into 4Q24
5M ago
CLNN
Clene reports Q2 EPS ($1.06), consensus ($1.49)
PremiumThe Fly
Clene reports Q2 EPS ($1.06), consensus ($1.49)
5M ago
CLNN
Clene target adjusted to $97 on reverse split at Rodman & Renshaw
PremiumThe Fly
Clene target adjusted to $97 on reverse split at Rodman & Renshaw
6M ago
CLNN
Canaccord reiterates Buy rating on Clene following ‘intriguing’ new data
PremiumThe Fly
Canaccord reiterates Buy rating on Clene following ‘intriguing’ new data
6M ago
BIIB
CLNN
Clene target adjusted to $31 from $7 at H.C. Wainwright
PremiumThe Fly
Clene target adjusted to $31 from $7 at H.C. Wainwright
6M ago
CLNN
Clene announces new CNM-Au8 biomarker, efficacy data
PremiumThe FlyClene announces new CNM-Au8 biomarker, efficacy data
6M ago
CLNN
Clene announces plans to submit briefing book to U.S. FDA
Premium
The Fly
Clene announces plans to submit briefing book to U.S. FDA
6M ago
CLNN
Clene trading halted, news pending
Premium
The Fly
Clene trading halted, news pending
6M ago
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >